Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Patrys.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Health Kick Podcast: Can listed Aussie drug makers survive COVID-19?
Health & Biotech
Health: Patrys gets a bounce after a promising pre-clinical trial for metastatic cancer treatment
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Health: ResApp popping bottles in the ice as cough app finally gets approval; shares fly
Health & Biotech
Dr Boreham’s Crucible: ‘Robust’ biotech and Kerry Stokes as a backer, so what’s holding down Patrys’ share price?
Health & Biotech
Biotech: Patrys is up 41pc after getting very good at curing brain cancer – in mice
News
Tl;dr? Here are your Budget cliff notes on what’s in store for ASX small caps
Health & Biotech
‘Mice are a failed experiment’: Why you shouldn’t get revved up about pre-clinical trials
Health & Biotech
8 biotechs that either flew or sunk on clinical trial results in 2018
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
News
Lunchtime ASX small cap wrap: who’s still got a job for Christmas
Health & Biotech
Patrys’ cancer drug worked wonders in mice with breast cancer
Health & Biotech
Trying to pick the next Biotron or BARD1? Here’s what you need to know
Health & Biotech
